Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сколар Рок, Инк.filedCriticalСколар Рок, Инк.
Priority claimed from PCT/US2019/041373external-prioritypatent/WO2020014460A1/en
Publication of EA202190255A1publicationCriticalpatent/EA202190255A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Abstract
В настоящем документе раскрыты моноклональные антитела и их антигенсвязывающие фрагменты, способные селективно ингибировать TGF1 с высокой эффективностью. Кроме того, раскрыты родственные композиции, способы и терапевтическое применение.This document discloses monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGF1 with high efficiency. In addition, related compositions, methods and therapeutic uses are disclosed.
EA202190255A2019-04-012019-07-11
HIGHLY AFFORMAL, ISOFORM SELECTIVE TGF1 INHIBITORS AND THEIR APPLICATION
EA202190255A1
(en)